These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10574565)

  • 1. Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model.
    Shi J; Perry G; Aliev G; Smith MA; Ashe KH; Friedland RP
    Neuroreport; 1999 Oct; 10(15):3229-32. PubMed ID: 10574565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease.
    Friedland RP; Shi J; Lamanna JC; Smith MA; Perry G
    Ann N Y Acad Sci; 2000 Apr; 903():123-8. PubMed ID: 10818497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice.
    Shi J; Perry G; Berridge MS; Aliev G; Siedlak SL; Smith MA; LaManna JC; Friedland RP
    J Nucl Med; 2002 Aug; 43(8):1044-51. PubMed ID: 12163630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum β-amyloid peptides, α2-macroglobulin, complement factor H, and clusterin levels in APP/PS1 transgenic mice during progression of Alzheimer's disease.
    Wang D; Di X; Fu L; Li Y; Han X; Wu H; Cai L; Meng X; Jiang C; Kong W; Su W
    Neuroreport; 2016 Oct; 27(15):1114-9. PubMed ID: 27541273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system.
    Davies TA; Long HJ; Eisenhauer PB; Hastey R; Cribbs DH; Fine RE; Simons ER
    Amyloid; 2000 Sep; 7(3):153-65. PubMed ID: 11019856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
    Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
    J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased permeability of the blood-brain barrier and Alzheimer's disease-like alterations in slit-2 transgenic mice.
    Li JC; Han L; Wen YX; Yang YX; Li S; Li XS; Zhao CJ; Wang TY; Chen H; Liu Y; Qi CL; He XD; Gu QL; Ye YX; Zhang Y; Huang R; Wu YE; He RR; Kurihara H; Song XY; Cao L; Wang LJ
    J Alzheimers Dis; 2015; 43(2):535-48. PubMed ID: 25114073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double A beta in human A betaPP transgenic mice.
    Davis J; Xu F; Miao J; Previti ML; Romanov G; Ziegler K; Van Nostrand WE
    Neurobiol Aging; 2006 Jul; 27(7):946-54. PubMed ID: 16105708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
    Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
    Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
    FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
    Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
    Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
    Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.
    Xu G; Ran Y; Fromholt SE; Fu C; Yachnis AT; Golde TE; Borchelt DR
    Acta Neuropathol Commun; 2015 Nov; 3():72. PubMed ID: 26566997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.